OpenEvidence Secures $210M to Revolutionize Medical Search and Longevity
OpenEvidence, a rapidly growing medical AI platform used by over 40% of U.S. physicians, announced a $210 million Series B funding round at a $3.5 billion valuation, and launched OpenEvidence DeepConsult™, an AI agent designed to assist physicians with advanced medical research, aiming to improve clinical decision-making and patient outcomes.